scispace - formally typeset
P

Pierre Coursaget

Researcher at François Rabelais University

Publications -  152
Citations -  6593

Pierre Coursaget is an academic researcher from François Rabelais University. The author has contributed to research in topics: Hepatitis B virus & Hepatitis B. The author has an hindex of 48, co-authored 150 publications receiving 6362 citations. Previous affiliations of Pierre Coursaget include French Institute of Health and Medical Research & Institut national de la recherche agronomique.

Papers
More filters
Journal ArticleDOI

Clinician's guide to human papillomavirus immunology: knowns and unknowns.

TL;DR: Despite growing understanding, many aspects of the interactions between HPV and the host immune system remain unknown, and this Review draws attention to several of these unresolved issues and their implications.
Journal ArticleDOI

Risk factors of invasive cervical cancer in Mali.

TL;DR: These data provide further evidence on the role of HPV in cervical cancer and show that high parity and poor genital hygiene conditions were the main co-factors for cervical cancer in this population with prevalent HPV infection.
Journal ArticleDOI

Immunisation against hepatitis b in man

TL;DR: An inactivated vaccine against hepatitis B was prepared from blood-donor HBs antigen purified on immunoadsorbents in a haemodialysis unit and tested in chimpanzees as discussed by the authors.
Journal ArticleDOI

Human Papillomavirus Types 16, 31, and 58 Use Different Endocytosis Pathways To Enter Cells

TL;DR: The early steps of the intracellular trafficking of human papillomavirus type 16, -31, and -58 pseudovirions were studied by investigating the effects of drugs acting at defined points of endocytosis pathways on virus-like particle-mediated pseudoinfection by overexpression of a dominant-negative form of the Eps15 protein to inhibit clathrin-mediated endocyTosis.
Journal ArticleDOI

Prevalence of Hepatitis B and C Viral Markers in Black and White Patients With Hepatocellular Carcinoma in the United States

TL;DR: The results indicate that the presence of anti-HCV was a significant risk factor for hepatocellular carcinoma, and a synergistic effect on risk was observed when both hepatitis B and C viral markers were present in peripheral blood.